Use of a variety of biological parameters in distinguishing cirrhotic from malignant ascites

International Journal of Biological Markers

Volumn 16, Issue 1, 2001, Pages 45-49

  Alexandrakis, M G ^a   Moschandrea, J ^a   Kyriakou, D S ^a   Alexandraki, R ^a   Kouroumalis, E ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

Acute phase proteins; Cirrhosis; Cytokines; Peritoneal effusion

Indexed keywords

ACUTE PHASE PROTEIN; ALBUMIN; ALPHA 1 ANTITRYPSIN; ALPHA 2 MACROGLOBULIN; ALPHA1 GLYCOPROTEIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CERULOPLASMIN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; CYTOKINE; FERRITIN; HAPTOGLOBIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; LACTIC ACID; PROTEIN; TRANSFERRIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANALYTICAL PARAMETERS; ANALYZER; ARTICLE; ASCITES; ASCITES FLUID ANALYSIS; BIOCHEMISTRY; BLOOD ANALYSIS; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARTMENT MODEL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; EFFUSION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LIVER CIRRHOSIS; MALE; MALIGNANT NEOPLASTIC DISEASE; MULTIVARIATE ANALYSIS; NEPHELOMETRY; PERITONEAL DISEASE; PREDICTION; RELIABILITY; STATISTICAL ANALYSIS;

EID: 0035080540     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.1177/172460080101600106     Document Type: Article

References (25)

1. Value of ascitic lipids in the differentiation between cirrhotic and malignant ascites
2. Fibronectin concentration in ascites differentiates between malignant and non malignant ascites
3. Ascitic fluid analysis for the differentiation of malignancy-related and non malignant ascites
4. Diagnosing ascitic biology on a biochemical basis
5. Diagnosing ascites: Value of ascitic fluid total protein, albumin, cholesterol, their ratios, serum-ascites albumin and cholesterol gradient
6. Malignant ascites: Clinical and experimental observations
7. Cytology of serous effusions: An investigation into the usefulness of cell blocks versus smears
8. Diagnostic value of the estimation of glucose in ascitic fluid
9. Analysis of ascitic fluid in cirrhosis
10. White count, pH, and lactate in ascites in the diagnosis of spontaneous bacterial peritonitis
11. Carcinoembryonic antigen titers on effusion fluid
12. Diagnostic value of ascitic fluid lactic dehydrogenase, protein and W13C levels
13. Serum ascites albumin concentration gradient and ascites fibronectin in the diagnosis of malignant ascites
14. Usefulness of serum-ascites albumin difference in separating transudative from exudative ascites. Another look
15. Detection of the TP 53 tumour suppressor gene product and P53 auto-antibodies in the ascites of women with ovarian cancer
16. Identification of oncofetal fibronectin in patients with advanced epithelial ovarian cancer: Detection in ascitic fluid and localization to primary sites and metastatic implants
17. Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: Correlation with clinicopathology and patient survival and analysis of serum VEGF levels
18. Ascitic interleukin-12 is an independent prognostic factor in ovarian cancer
19. Calretinin. A selective marker of normal and neoplastic mesothelial cells in serous effusions
20. The cell adhesion molecule, E-cadherin, distinguishes mesothelial cells from carcinoma cells in fluids
21. Effusion cytology of hepatocellular carcinoma with in situ hybridisation for human albumin
22. Statistical models
23. TPS and CA125 levels in serum cyst fluid and ascites of patients with epithelial ovarian neoplasms